Management of histologic LSIL (CIN 1) in patients younger than 25 years

This algorithm describes management of histologic LSIL (CIN 1) in patients younger than 25 years.

LSIL: low-grade squamous intraepithelial lesion; CIN: cervical intraepithelial neoplasia; ASC-US: atypical squamous cells of undetermined significance; ASC-H: atypical squamous cells cannot exclude HSIL; HSIL: high-grade squamous intraepithelial lesion; ASCCP: American Society for Colposcopy and Cervical Pathology; NILM: negative for intraepithelial lesion or malignancy; AGC: atypical glandular cell; HPV: human papillomavirus.
* Cytology if age <25 years; HPV-based testing if ≥25 years.

From: Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis 2020; 24:102. DOI: 10.1097/LGT.0000000000000525. Copyright © 2020 the American Society for Colposcopy and Cervical Pathology. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.

Graphic 127914 Version 3.0

خرید پکیج

Management of histologic LSIL (CIN 1) in patients younger than 25 years